Literature DB >> 31440829

Pharmacotherapy of psychiatric inpatients with adjustment disorder: current status and changes between 2000 and 2016.

Timo Greiner1, Beatrice Haack2, Sermin Toto3, Stefan Bleich3, Renate Grohmann4, Frank Faltraco5, Martin Heinze2, Michael Schneider2.   

Abstract

Adjustment disorder is a temporary change in behaviour or emotion as a reaction to a stress factor. Therapy consists of psychotherapy, and pharmacotherapy can be advised. However, data on the real-life pharmacological treatment are sparse. Prescription data for 4.235 psychiatric inpatients diagnosed with adjustment disorder in the time period 2000-2016 were analysed. The data were obtained from the Drug Safety Programme in Psychiatry (AMSP). Data were collected on two reference days per year; prescription patterns and changes over time were analysed. Of all patients, 81.2% received some type of psychotropic drug. Mostly antidepressants (59.8%), antipsychotics (35.5%), and tranquilisers (22.6%) were prescribed. Prescription rates for antidepressants decreased slightly over the years, while rates for antipsychotics increased, especially for atypical antipsychotics. It is important to note that the diagnosis "adjustment disorder" is most likely a working diagnosis that is used for patients in immediate need of psychiatric aid. Overall, pharmacotherapy for inpatients with this diagnosis is mostly symptom-oriented and focuses on depressive moods, agitation and anxiety. Therapy regimes changed over time and show an increased use of atypical antipsychotics with sedative properties. However, for most of the medication, there are neither evidence-based studies nor guidelines, and drugs might be contraindicated in some cases.

Entities:  

Keywords:  AMSP; Adjustment disorder; Antidepressant; Antipsychotic; Psychopharmaceuticals

Mesh:

Substances:

Year:  2019        PMID: 31440829     DOI: 10.1007/s00406-019-01058-1

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  33 in total

1.  Adjustment disorders: fault line in the psychiatric glossary.

Authors:  P Casey; C Dowrick; G Wilkinson
Journal:  Br J Psychiatry       Date:  2001-12       Impact factor: 9.319

Review 2.  The AMSP drug safety program: methods and global results.

Authors:  R Grohmann; R R Engel; E Rüther; H Hippius
Journal:  Pharmacopsychiatry       Date:  2004-03       Impact factor: 5.788

3.  Psychopharmacological treatment of 2195 in-patients with borderline personality disorder: A comparison with other psychiatric disorders.

Authors:  René Bridler; Anne Häberle; Sabrina T Müller; Katja Cattapan; Renate Grohmann; Sermin Toto; Siegfried Kasper; Waldemar Greil
Journal:  Eur Neuropsychopharmacol       Date:  2015-04-11       Impact factor: 4.600

4.  Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder.

Authors:  Nicholas Moore; Hélène Verdoux; Bruno Fantino
Journal:  Int Clin Psychopharmacol       Date:  2005-05       Impact factor: 1.659

5.  Efficacy and safety of trazodone versus clorazepate in the treatment of HIV-positive subjects with adjustment disorders: a pilot study.

Authors:  S De Wit; L Cremers; D Hirsch; C Zulian; N Clumeck; N Kormoss
Journal:  J Int Med Res       Date:  1999 Sep-Oct       Impact factor: 1.671

6.  Diagnosis of nonpsychotic patients in community clinics.

Authors:  M K Shear; C Greeno; J Kang; D Ludewig; E Frank; H A Swartz; M Hanekamp
Journal:  Am J Psychiatry       Date:  2000-04       Impact factor: 18.112

Review 7.  Adjustment disorder: A diagnosis whose time has come.

Authors:  Rahel Bachem; Patricia Casey
Journal:  J Affect Disord       Date:  2017-10-23       Impact factor: 4.839

8.  Benzodiazepines: dependence and withdrawal.

Authors:  F J Ayd
Journal:  JAMA       Date:  1979-09-28       Impact factor: 56.272

9.  Pharmacotherapy of anxiety disorders in German-speaking countries: current status and changes between 1994 and 2011.

Authors:  Anna K Holl; Renate Grohmann; Martin Letmaier; Annamaria Painold; Sabrina Mörkl; Sermin Toto; Siegfried Kasper
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-08-20       Impact factor: 5.270

10.  Depressive disorders in Europe: prevalence figures from the ODIN study.

Authors:  J L Ayuso-Mateos; J L Vázquez-Barquero; C Dowrick; V Lehtinen; O S Dalgard; P Casey; C Wilkinson; L Lasa; H Page; G Dunn; G Wilkinson
Journal:  Br J Psychiatry       Date:  2001-10       Impact factor: 9.319

View more
  2 in total

1.  Prescription Pattern and Follow-up Pattern in Psychiatric Outpatients with Adjustment Disorder.

Authors:  Parthasarathy Ramamurthy; Aneesh Alexander; Susan Solomon; Pradeep Thilakan
Journal:  Indian J Psychol Med       Date:  2021-07-02

2.  Pharmacotherapy of 1,044 inpatients with posttraumatic stress disorder: current status and trends in German-speaking countries.

Authors:  Matthias A Reinhard; Johanna Seifert; Timo Greiner; Sermin Toto; Stefan Bleich; Renate Grohmann
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-12-28       Impact factor: 5.270

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.